Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2026-05-27 @ 7:06 AM
Study NCT ID:
NCT02454556
Status:
COMPLETED
Last Update Posted:
2017-02-24
First Post:
2015-05-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized, Multicentre, Open Label, Evaluator Blinded Study to Evaluate Safety and Efficacy of Folitime® of Gemabiotech S.A., Versus Gonal-f ® of Merck Serono, in Patients With Infertility Undergoing ART
Sponsor:
Gema Biotech S.A.
Organization: